Clinical Trials on Human Milk in Australia

Total 476 results

National Cancer Institute (NCI)

Not yet recruiting

Testing RG1-VLP Vaccine to Prevent HPV-related Cancers

Human Papillomavirus-Related Carcinoma

United States, Austria
Bayside Health
University of Adelaide

Unknown

Pharmacogenomics of Interferon and Ribavirin Treatment in Patients With Chronic Hepatitis C Virus Infection

Hepatitis C

Australia
GlaxoSmithKline

Completed

A First Time in Human Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single & Repeat Escalating Doses of GSK2878175 in Healthy Subjects

Hepatitis C, Chronic

Australia
Actinogen Medical

Recruiting

Effect of 10 mg Xanamem on Dementia Due to Alzheimer's Disease (XanaMIA)

Alzheimer Disease | Dementia, Mild | Dementia Moderate

Australia
Kirby Institute

Completed

DAA-based Therapy for Recently Acquired Hepatitis C II (DAA = Directly Acting Antiviral) (DARE-C II)

Hepatitis C

Australia, New Zealand
Kirby Institute
National Institutes of Health (NIH); The University of New South Wales

Completed

Australian Trial in Acute Hepatitis C

Hepatitis C

Australia
Kirby Institute

Recruiting

Treatment of HOsPitalised Inpatients for Hepatitis C (TOPIC): Therapeutic Intervention Enhancing Care Linkage in People Who Inject Drugs (TOPIC)

Hepatitis C | Liver Cirrhoses | Liver Inflammation

Australia
Kirby Institute

Completed

Treatment of Recently Acquired Hepatitis C Virus Infection (ATAHC-II)

Acute Hepatitis C

Australia
Life Molecular Imaging SA

Completed

Florbetaben (BAY94-9172) PET (Positron Emission Tomography) Imaging in MCI (Mild Cognitive Impairment) Patients

Alzheimer Disease | Amyloid Beta-Protein

Australia
DiaSorin Molecular LLC

Completed

LIAISON NES Influenza (FLU) A/B & Coronavirus Disease 2019 (COVID-19) Clinical Agreement in Australia

Coronavirus Disease 2019 | Influenza A | Influenza Type B

Australia
University of Dundee
Burnet Institute; Public Health Wales

Completed

Reaching mEthadone Users Attending Community pHarmacies With HCV (REACH HCV)

Hepatitis C

Australia, United Kingdom
Kirby Institute

Completed

Hepatitis B Acceptability and Vaccination Incentive Trial (HAVIT)

Hepatitis B

Australia
Arrowhead Pharmaceuticals

Withdrawn

Study of ARC-520 in Patient With Chronic Hepatitis B Virus

Chronic Hepatitis B

Australia
Delenex Therapeutics AG

Completed

Intra-dermal Injections of DLX105 Into Lesional Skin in Patients With Mild-to-moderate Psoriasis Vulgaris (2011-00500-15)

Mild-to-moderate Psoriasis Vulgaris

Austria, Germany
Macfarlane Burnet Institute for Medical Research...
St Vincent's Hospital Melbourne

Unknown

The TAP Study: Treating People Who Inject Drugs in Community-Based Settings Using a Social Network Approach (TAP)

Hepatitis C | Drug Abuse, Intravenous

Australia
Bayside Health
Gilead Sciences

Unknown

A Surveillance Program for the Detection of Hepatitis B Virus (HBV) Resistance to Tenofovir in HIV-HBV co-Infected Patients

HIV Infections | Hepatitis B Virus

Australia
Starpharma Pty Ltd
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

SPL7013 Gel - Male Tolerance Study

Human Immunodeficiency Virus (HIV)

Australia
University of East Anglia
University of Illinois at Chicago; Swinburne University of Technology

Completed

The Cognitive Ageing Nutrition and Neurogenesis (CANN) Trial (CANN)

Mild Cognitive Impairment | Subjective Memory Impairment

United States, Australia, United Kingdom
Kirby Institute
Bristol-Myers Squibb

Withdrawn

Impact of HCV Treatment on Neurocognitive Functions and Brain Metabolism (HEPCOG-II)

Hepatitis C, Chronic

Australia
University of Melbourne
Melbourne Health; National Institute of Allergy and Infectious Diseases (NIAID) and other collaborators

Completed

Effect of High Dose Vitamin D Supplementation on HIV Latency (VIVA)

Human Immunodeficiency Virus

Australia
bioLytical Laboratories
St Vincent's Hospital Melbourne

Not yet recruiting

A Study to Evaluate Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Sites

Hepatitis B | Hepatitis B Infection

Australia
The University of Queensland
Johns Hopkins University; Royal Brisbane and Women's Hospital; Queensland University... and other collaborators

Recruiting

Uncovering a Novel Therapeutic Target to Reduce Dementia Risk in Parkinson's Disease (TRIP)

Parkinson Disease | Mild Cognitive Impairment | Memory Impairment

Australia
Kirby Institute

Completed

A Phase IV Trial of Paritaprevir/Ritonavir, Ombitasvir, Dasabuvir for Chronic Hepatitis C Genotype 1 Virus Infection (D3FEAT)

Hepatitis C, Chronic

Australia
St Vincent's Hospital Melbourne
National Health and Medical Research Council, Australia

Unknown

Determinants of Virological Response After Discontinuation of Nucleoside Analogue Therapy in Hepatitis B Patients (STOP)

Chronic Hepatitis B.

Australia
Enyo Pharma
CPR Pharma Services Pty Ltd, Australia

Completed

Evaluation of the Safety and Pharmacology of EYP001 in HBV Subjects

Hepatitis B, Chronic

Thailand, Netherlands, Australia, Poland
Gilead Sciences

Completed

CHARM: Chronic Hepatitis B Antihepadnaviral Resistance Mutation Study (CHARM)

Chronic Hepatitis B

Australia
Kirby Institute

Withdrawn

Evaluation of Novel Point of Care Hepatitis B Diagnostic Assays

Hepatitis B

Australia
Kirby Institute
University of Public Health, Myanmar

Completed

Simplified Monitoring Myanmar SM2 Study (SM2)

HIV Infections | Hepatitis C | Liver Cirrhoses | Liver Inflammation

Australia
GlaxoSmithKline

Completed

Long Term Follow-up Study at Years 2, 3, 4 and 5 Where 2 Dosing Schedules of the Combined Hepatitis A and B Vaccine Were Compared

Hepatitis B | Hepatitis A

Australia, Belgium, Spain
Kirby Institute

Completed

Surveillance and Treatment of Prisoners With Hepatitis C (SToP-C)

Hepatitis C

Australia
Kirby Institute

Terminated

Scale-up of Treatment of Hepatitis C Infection Among People Who Inject Drugs (DARLO-C)

Hepatitis C

Australia
Kirby Institute

Recruiting

Real World Assessment of People Living With Chronic Hepatitis B in Australia (REACH-B)

Hepatitis B

Australia
Bayside Health
National Institutes of Health (NIH); Monash Medical Centre

Unknown

Innate Immunity in HIV Positive Patients Co-infected With Hepatitis C Virus (HCV) or Hepatitis B Virus (HBV)

HIV Infections | HIV-hepatitis Co-infection

Australia
University of Sydney

Active, not recruiting

Sleep Disturbance in MCI: A Study of a Cognitive Behavioural Therapy Digital Intervention (SUCCEED)

Sleep Wake Disorders | Insomnia | Cognitive Dysfunction | Mild Cognitive Impairment | Cognitive Disorder

Australia
AVIR Green Hills Biotechnology AG

Completed

Dose Finding Study of Single Dose GHB11L1 in Healthy Adults (GHB-CS07)

Influenza, Human

Austria
Kirby Institute

Recruiting

Evaluation of Hepatitis B Virus (HBV) DNA Test as Point of Care Tool (HBVPOCT)

Hepatitis B

Australia
Kirby Institute

Completed

A Phase II Trial of Sofosbuvir (SOF) and GS-5816 for People With Chronic Hepatitis C Virus Infection and Recent Injection Drug Use (SIMPLIFY)

Hepatitis C

Australia
Arrowhead Pharmaceuticals

Completed

Study of ARO-HBV in Normal Adult Volunteers and Patients With Hepatitis B Virus (HBV)

Hepatitis B

Australia, Hong Kong, New Zealand
ModernaTX, Inc.

Recruiting

A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months

Respiratory Syncytial Virus | Human Metapneumovirus

United Kingdom, Spain, United States, Australia, Canada, Poland, South Africa, Panama
AVIR Green Hills Biotechnology AG

Completed

Study of Single Dose GHB16L2 Trivalent Influenza Vaccine in Healthy Adults

Influenza, Human

Austria
GlaxoSmithKline

Completed

Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination Schedules of Combined Hepatitis A & B Vaccine

Hepatitis B | Hepatitis A

Australia
Ology Bioservices

Completed

Safety and Immunogenicity Study of a Booster Vaccination With a Non-Adjuvanted H5N1 Influenza Vaccine (Follow Up to Study 810501)

Influenza

Austria
Ellume Pty Ltd

Completed

Validation of the Ellume® Respirio Flu Test and the Ellume® eLab Flu Test for the Rapid Identification of Influenza A/B

Influenza A | Influenza B

Australia
GlaxoSmithKline

Completed

Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 19-40 y

Hepatitis B

Austria
Atridia Pty Ltd.

Recruiting

A Trial of SHR-1707 Infusion in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease

Alzheimer's Disease (AD)

Australia
Kirby Institute

Completed

Direct-acting Antiviral Therapy and Reinfection Among People With Chronic Hepatitis C Virus Infection and Recent Injecting Drug Use in the Prison Setting (SHARP-P)

Hepatitis C, Chronic

Australia
St Vincent's Hospital Melbourne
Merck Sharp & Dohme LLC

Unknown

A Pilot Study of Boceprevir for the Treatment of Genotype 6 HCV (HCV-6)

Chronic Hepatitis C

Australia
Janssen-Cilag Pty Ltd

Completed

Prospective Research in Memory Clinics (PRIME)

Dementia | Mild Cognitive Impairment

Australia
Medical University of Graz

Completed

Immune and Metabolic Effects of Vitamin D Supplementation in Healthy Humans

Healthy Humans

Austria
Boehringer Ingelheim

Withdrawn

Open Label Trial to Compare BI 207127 to Telaprevir in HCV Patients

Hepatitis C, Chronic

Australia, Spain, Sweden

Clinical Trials on Human Milk in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations